ToxiProofAI Safe Treatments for Every Patient, Powered by AI-PGx
Personalised Precision Medicine Efficacy & Safety
ToxiProofAI Safe Treatments for Every Patient, Powered by AI-PGx
Personalised Precision Medicine Efficacy & Safety
Our Mission
Our commitment to personalised drug safety & efficacy using AI-driven Pharmacogenomics (PGx)
ToxiProofAI is pioneering the future of personalised drug safety. As new therapies rapidly enter clinical trials, our team harnesses advanced biosensors, cutting-edge technology, and deep toxicology expertise to deliver personalized precision safety medicine. We stay ahead of emerging drug trends to ensure the rigorous evaluation of novel compounds, setting the standard for safety in pharmaceutical innovation.
Solutions & Innovations
PGx Discovery Flywheel
PGx Discovery Flywheel
PGx Discovery Flywheel
Where AI meets biology to uncover hidden safety signals before they reach patients.
MySafety
PGx Discovery Flywheel
PGx Discovery Flywheel
Your go-to source for safety, dosing, and toxicity details about the chemicals around you.
MyVigilance
PGx Discovery Flywheel
Clinical Trial Support
A secure, cloud-based app that keeps patients and doctors continuously informed about a patient’s health.
Clinical Trial Support
PGx Discovery Flywheel
Clinical Trial Support
Optimise clinical trial design and dosing strategies with predictive efficacy, safety modelling.
Preclinical R&D Support
Preclinical R&D Support
Preclinical R&D Support
De-risk your pipeline with tailored PGx insights and toxicology validation at the preclinical stage.
PGx Database
Preclinical R&D Support
Preclinical R&D Support
Ready-to-use proprietary biosensor libraries for rapid safety and efficacy screening.
PGx Knowledge base
Preclinical R&D Support
PGx Knowledge base
Your trusted resource for PGx science, safety analytics, and latest regulatory insights.
FAQs
Preclinical R&D Support
PGx Knowledge base
Clear answers to your most important questions about our technology and services.
Newsletter
Upcoming opportunities to meet us
- Disruptive Technologies for clinical trials [January 2026]
- Festival of Genomics & Big Data [January 2026]
NHS Genomics Health Summit
In December 2025, we participated in NHS Genomics Health Summit in London, connecting with scientific leaders, regulatory officers, policy makers, health economists, clinicians, genetic consultants and exploring AI-driven innovations in healthcare supporting the UK’s 10-Year Health Plan.
Read our LinkedIn post here: https://tinyurl.com/4n4nf5y4
The European AI conference
In December 2025, we participated in The European AI Conference 2025 at the Google London office, joined roundtable discussions, built new connections in the AI community, and exchanged perspectives on emerging trends, collaboration, and responsible AI development.
Read our LinkedIn post here: https://tinyurl.com/4cerrccw
Biotechgate Digital Partnering Virtual Event
In December 2025, we participated in the Biotechgate Digital Partnering Virtual Event 2025, engaging with global biotech leaders to explore collaborations and innovation opportunities.
Read our LinkedIn post here: https://tinyurl.com/49ukz7th
UK Biobank Scientific Conference
In December 2025, at the UK Biobank Scientific Conference 2025 at Queen Elizabeth II centre, we were thrilled to join discussions on advancing biomedical research through privacy-preserving, federated learning from human data. It was a day of inspiring talks, meaningful connections, and exciting new collaboration opportunities.
Read our LinkedIn post here: https://tinyurl.com/bdfnsbv8
NHS England PGx and Medicines Optimisation: Network of Excellence event
In November 2025, we participated in the NHS England Pharmacogenomics and Medicines Optimisation – Network of Excellence event at Manchester. Our CEO and Founder, Chandan Seth Nanda, discussed with participants how we are driving AI-powered innovation in pharmacogenomics to enhance personalized precision medicine safety.
Read our LinkedIn post here: https://tinyurl.com/4et7zp82
London HealthTech Roundtable
In October 2025, we attended the London Healthtech Roundtable 2025, hosted by the London Venture Capital Network—uniting investors, founders, scientists, and family offices driving the future of health and life sciences.
Read our LinkedIn post here: https://tinyurl.com/yped2a37
Drug Discovery Biology and Bioinformatics Strategy Meeting
In October 2025, we participated in the Drug Discovery Strategy Summit in London. Chandan shared insights on fit-for-purpose data for federated AI in target, biomarker, and drug discovery.
Read our LinkedIn post here: https://tinyurl.com/ywrs2n7d
